Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ramunni

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenomaE Arvat, R Giordano, J Ramunni, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humansE Ghigo, L Gianotti, E Arvat, et al.
Clinical Endocrinology|September 1, 1999
Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese womenM Maccario, E Mazza, J Ramunni, et al.
Dementia (Basel, Switzerland)|September 1, 1996
The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndromeE Arvat, L Gianotti, L Ragusa, et al.
Clinical Endocrinology|September 27, 2003
Suppression and recovery of LH secretion by a potent and selective GnRH-receptor antagonist peptide in healthy early follicular-phase women are mediated via selective control of LH secretory burst massL Gianotti, J D Veldhuis, S Destefanis, et al.
Journal of Endocrinological Investigation|March 27, 2001
Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humansL Gianotti, J Ramunni, F Lanfranco, et al.
Journal of Endocrinological Investigation|May 31, 2002
Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humansS Grottoli, B Maccagno, J Ramunni, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 20, 1999
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patientsM Maccario, J Ramunni, S E Oleandri, et al.
Neuroendocrinology|June 26, 1998
Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
Panminerva Medica|August 5, 1998
IGF-I levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiencyM Maccario, S Grottoli, G Aimaretti, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenomaE Arvat, R Giordano, J Ramunni, et al.
The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humansE Ghigo, L Gianotti, E Arvat, et al.
Clinical Endocrinology|September 1, 1999
Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese womenM Maccario, E Mazza, J Ramunni, et al.
Dementia (Basel, Switzerland)|September 1, 1996
The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndromeE Arvat, L Gianotti, L Ragusa, et al.
Clinical Endocrinology|September 27, 2003
Suppression and recovery of LH secretion by a potent and selective GnRH-receptor antagonist peptide in healthy early follicular-phase women are mediated via selective control of LH secretory burst massL Gianotti, J D Veldhuis, S Destefanis, et al.
Journal of Endocrinological Investigation|March 27, 2001
Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humansL Gianotti, J Ramunni, F Lanfranco, et al.
Journal of Endocrinological Investigation|May 31, 2002
Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humansS Grottoli, B Maccagno, J Ramunni, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 20, 1999
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patientsM Maccario, J Ramunni, S E Oleandri, et al.
Neuroendocrinology|June 26, 1998
Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humansE Arvat, B Maccagno, J Ramunni, et al.
Panminerva Medica|August 5, 1998
IGF-I levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiencyM Maccario, S Grottoli, G Aimaretti, et al.
Pageof 5